Moreover, given that many types of resistance mechanisms to PARPi are already being described (D’Andrea, 2018; Noordermeer and van Attikum, 2019), there is a major interest in developing alternative SL strategies to target BRCA1 deficiency from different angles. Here, BRCA1 is linked to hyperinsulinemic hypoglycemia, familial, 4.